LONDON (Reuters) -AstraZeneca Chief Executive Pascal Soriot said on Friday the company is “very encouraged” by interim data from a key lung cancer drug trial, but he did not explain why the company had not declared results as “clinically meaningful”. Read full story
AstraZeneca CEO says lung cancer drug trial data 'very encouraging'
